NYSE American - Nasdaq Real Time Price USD
Theriva Biologics, Inc. (TOVX)
As of 2:27 PM EST. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 868,773 | 11 |
Sales | 150,565 | 1 |
Net Shares Purchased (Sold) | 718,208 | 12 |
Total Insider Shares Held | 105.39k | -- |
% Net Shares Purchased (Sold) | -117.20% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
SHALLCROSS STEVEN A Chief Executive Officer | Purchase at price 0.69 per share. | Direct | 9,703 | Jun 7, 2023 |
SHALLCROSS STEVEN A Chief Executive Officer | Purchase at price 0.63 per share. | Direct | 16,453 | Jun 6, 2023 |
SHALLCROSS STEVEN A Chief Executive Officer | Purchase at price 1.04 per share. | Direct | 26,075 | Feb 10, 2023 |
SHALLCROSS STEVEN A Chief Executive Officer | Purchase at price 0.94 per share. | Direct | 23,512 | Feb 2, 2023 |
SHALLCROSS STEVEN A Chief Executive Officer | Purchase at price 0.87 per share. | Direct | 21,825 | Jan 25, 2023 |
SHALLCROSS STEVEN A Chief Executive Officer | Purchase at price 0.75 per share. | Direct | 18,705 | Jan 20, 2023 |
SHALLCROSS STEVEN A Chief Executive Officer | Purchase at price 0.44 per share. | Direct | 43,700 | Dec 29, 2022 |
SHALLCROSS STEVEN A Chief Executive Officer | Purchase at price 0.49 per share. | Direct | 24,595 | May 10, 2021 |
SHALLCROSS STEVEN A Chief Executive Officer | Purchase at price 0.42 per share. | Direct | 20,785 | Aug 23, 2019 |
KIRK RANDAL JOE Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.65 - 0.67 per share. | Indirect | 98,837 | Apr 3, 2019 |
KRAWS JEFFREY J Director | Conversion of Exercise of derivative security at price 0.09 per share. | Direct | 20,590 | Mar 14, 2017 |
TARRIFF SCOTT L Director | -- | Direct | -- | Nov 18, 2016 |
WOLF JEFFREY ALAN J.D. Director | Conversion of Exercise of derivative security at price 0.09 per share. | Direct | 976 | Apr 1, 2015 |
BALLANTYNE CHARLES EVAN Chief Financial Officer | Purchase at price 1.35 per share. | Direct | 13,500 | May 22, 2014 |
KANZER STEVE H Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.43 per share. | Indirect | 7,154,333 | Apr 30, 2014 |
KANZER STEVE H Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.10 - 2.86 per share. | Indirect | 685,670 | Apr 29, 2014 |
KIRK RANDAL JOE Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.00 per share. | Indirect | 2,500,000 | Dec 17, 2013 |
RILEY JEFFREY SCOTT Chief Executive Officer | Purchase at price 1.71 - 1.74 per share. | Direct | 5,046 | Jan 7, 2013 |
RILEY JEFFREY SCOTT Chief Executive Officer | Purchase at price 1.75 - 1.78 per share. | Direct | 9,705 | Jan 3, 2013 |
RILEY JEFFREY SCOTT Chief Executive Officer | Purchase at price 1.71 per share. | Direct | 3,420 | Jan 3, 2013 |
KIRK RANDAL JOE Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.30 per share. | Indirect | 7,187,500 | Oct 29, 2012 |
KUO JAMES S Chief Executive Officer | Purchase at price 0.69 per share. | Direct | 3,103 | Aug 30, 2011 |
LYON LYMAN MAX JR Chief Executive Officer | Stock Award(Grant) at price 0.52 per share. | Direct | 23,400 | Dec 7, 2009 |
RUDICK A JOSEPH JR Director | Conversion of Exercise of derivative security at price 0.09 per share. | Direct | 2,440 | Jan 29, 2008 |
DORMAN DANIEL J Director | Conversion of Exercise of derivative security at price 2.22 per share. | Indirect | 563,283 | Nov 9, 2007 |
RIDGEBACK CAPITAL INVESTMENTS LTD Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 0.74 per share. | Indirect | 457,953 | Nov 9, 2007 |
KANZER STEVE H Chief Executive Officer | Purchase at price 7.09 - 7.42 per share. | Indirect | 103,281 | Jul 25, 2007 |
KANZER STEVE H Chief Executive Officer | Purchase at price 7.00 - 7.24 per share. | Indirect | 57,025 | Jul 24, 2007 |
KANZER STEVE H Chief Executive Officer | Purchase at price 6.58 - 6.90 per share. | Direct | 200,351 | Jul 23, 2007 |
KANZER STEVE H Chief Executive Officer | Purchase at price 5.10 - 5.47 per share. | Direct | 131,171 | Jul 17, 2007 |
KANZER STEVE H Chief Executive Officer | Purchase at price 0.67 - 5.24 per share. | Indirect | 5,139,837 | Jul 16, 2007 |
KANZER STEVE H Chief Executive Officer | Purchase at price 0.00 - 5.24 per share. | Indirect | 391,962 | Jul 16, 2007 |
BISGAIER CHARLES L President | Purchase at price 4.64 per share. | Direct | 46,400 | Jul 16, 2007 |
KANZER STEVE H Chief Executive Officer | Purchase at price 5.00 - 5.40 per share. | Direct | 140,350 | May 11, 2007 |
KANZER STEVE H Chief Executive Officer | Purchase at price 1.82 - 2.10 per share. | Direct | 445,580 | Apr 17, 2007 |
KANZER STEVE H Chief Executive Officer | Stock Award(Grant) at price 1.25 per share. | Direct | 125,000 | Feb 27, 2007 |
KANZER STEVE H Chief Executive Officer | Stock Award(Grant) at price 1.05 per share. | Direct | 100,000 | Feb 21, 2007 |
BISGAIER CHARLES L President | Stock Award(Grant) at price 2.02 per share. | Indirect | 200,190 | Nov 2, 2006 |
MANION MICHAEL F Chief Executive Officer | Stock Award(Grant) at price 0.80 per share. | Direct | 349,040 | Jun 30, 2006 |
MANION MICHAEL F President | Purchase at price 0.01 per share. | Direct | 9,350 | May 31, 2006 |
MANION MICHAEL F President | Purchase at price 0.00 per share. | Direct | 223 | Sep 30, 2005 |
CURRAN JOHN Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.39 - 1.51 per share. | Indirect | 79,450 | Jun 28, 2002 |
CURRAN JOHN Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.01 - 2.10 per share. | Indirect | 314,845 | Apr 12, 2002 |
CURRAN JOHN Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.64 per share. | Indirect | 11,600 | Jan 2, 2002 |
CURRAN JOHN Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.73 - 4.61 per share. | Indirect | 564,550 | Dec 31, 2001 |
CURRAN JOHN Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.24 per share. | Indirect | 55,728 | Nov 15, 2001 |
CURRAN JOHN Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.56 per share. | Indirect | 53,400 | Oct 1, 2001 |
INPHARZAM INTERNATIONAL SA Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.99 per share. | Direct | 642,841 | Sep 28, 2001 |
PETERSON LOREN G Officer and Director | Stock Gift at price 3.88 per share. | Direct | 19,375 | Dec 20, 2000 |
HOFFMANN SCOTT A Chief Financial Officer | Purchase at price 2.69 - 2.88 per share. | Direct | 18,444 | May 27, 1999 |
Related Tickers
ATHA Athira Pharma, Inc.
0.7000
-6.67%
THAR Tharimmune, Inc.
2.8750
+3.79%
BNOX Bionomics Limited
0.3011
-38.92%
ZVSA ZyVersa Therapeutics, Inc.
1.5500
-38.98%
ENSC Ensysce Biosciences, Inc.
0.5222
+0.04%
NLSP NLS Pharmaceutics AG
4.1800
+3.47%
GLYC GlycoMimetics, Inc.
0.3681
-5.62%
GRI GRI Bio, Inc.
0.9490
-4.14%
TNYA Tenaya Therapeutics, Inc.
2.2500
+5.63%
AVTE Aerovate Therapeutics, Inc.
2.8000
+3.70%